Prevalence of osteopenia in men with prolactinoma

Journal of Endocrinological Investigation

Volumn 28, Issue 3, 2005, Pages 12-17

  Naliato, E C O ^a,b   Farias, M L F ^a   Braucks, G R ^a   Costa, F S R ^a   Zylberberg, D ^a   Violante, A H D ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Bone density; Densitometry; Hypogonadism; Men; Prolactinoma

Indexed keywords

ANDROGEN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTRADIOL; ESTROGEN; PROLACTIN; SEX HORMONE; TESTOSTERONE; HORMONE;

ADULT; AGED; ARTICLE; BONE DENSITOMETRY; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; PROLACTINOMA; ADOLESCENT; BLOOD; CROSS-SECTIONAL STUDY; DENSITOMETRY; METABOLIC BONE DISEASE; MIDDLE AGED; RADIODENSITOMETRY; REGRESSION ANALYSIS;

ADOLESCENT; ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; DENSITOMETRY; DENSITOMETRY, X-RAY; ESTROGENS; HORMONES; HUMANS; HYPERPROLACTINEMIA; HYPOGONADISM; MALE; MIDDLE AGED; OSTEOPOROSIS; PROLACTINOMA; REGRESSION ANALYSIS;

EID: 21344464647     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345523     Document Type: Article

References (34)

1. Vartej P, Poiana C, Vartej I. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol 2001, 15: 43-7.
2. Klibanski A, Greenspan S. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 1986, 315: 542-6.
3. Biller B, Baum H, Rosenthal D, Saxe V, Charpie P, Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1992, 75: 692-7.
4. Greenspan S, Neer R, Ridgway E, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986, 104: 777-82.
5. Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989, 110: 526-31.
6. Di Somma C, Colao A, Di Sarno A, et al. Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. J Clin Endocrinol Metab 1998, 83: 807-13.
7. Colao A, Di Somma C, Loche S, et al. Prolactinomas in adolescents: Persistance of bone loss after 2 years of prolactin normalization. Clin Endocrinol (Oxf) 2000, 52: 319-27.
8. Jackson J, Kleerekoper M, Parfitt M. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Intern Med 1986, 105: 543-5.
9. Prelevic G. Osteoporosis in men. J R Soc Med 2001, 94: 620-3.
10. Cummings S, Black D, Nevitt M, et al. Bone density at various sites for prediction of hip fractures. Lancet 1993, 341: 72-5.
11. Bonnick SL. Densitometric anatomy. In: Bonnick SL eds. Bone densitometry in clinical practice. Totowa, New Jersey: Humana Press Inc. 1998, 31-64.
12. Schlechte J, El-Khoury G, Kathol M, Walkner L. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab 1987, 64: 1021-6.
13. Benito M, Gomberg B, Wehrli F, et al. Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab 2003, 88: 1497-502.
14. Seeman E, Melton III L, O'Fallon W, Riggs B. Risk factors for spinal osteoporosis in men. Am J Med 1983, 75: 977-83.
15. Vestergaard P, Jorgensen J, Hagen C, et al. Fractures risk is increased in patients with deficiency or untreated prolactinomas - a case-control study. Clin Endocrinol (Oxf) 2002, 56: 159-67.
16. Colao A, Di Somma C, Piovonello R, et al. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999, 84: 1919-24.
17. Byers R, Hoyland J, Braidman I. Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 2001, 168: 353-62.
18. Holmes S, Economou G, Whitehouse R, Adams J, Shalet S. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994, 78: 669-74.
19. Ciccarelli E, Savino L, Carlevatto V, Bertagna A, Isaia G, Camanni F. Vertebral bone density in non-amenorrheic hyperprolactinaemic women. Clin Endocrinol (Oxf) 1988, 28: 1-6.
20. Klibanski A, Biller B, Rosenthal D, Schoenfeld D, Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 1988, 67: 124-30.
21. Nystrom E, Leman J, Lundberg P, et al. Bone mineral content in normally menstruating women with hyperprolactinaemia. Horm Res 1988, 29: 214-7.
22. Finkelstein J, Klibanski A, Neer R. A longitudinal evaluation of bone mineral density in adult men histories of delayed puberty. J Clin Endocrinol Metab 1990, 81: 1152-5.
23. Guo C, Jones T, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density & bone turnover. J Clin Endocrinol Metab 1997, 82: 658-65.
24. Mittan D, Lee S, Miller E, Perez R, Basler J, Bruder J. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 2002, 87: 3656-61.
25. Carter J, Tyson J, Tolis G, Van Vliet S, Faiman C, Friesen H. Prolactin-secreting tumors and hypogonadism in 22 men. N Engl J Med 1978, 299: 847-52.
26. Pinzone J, Katznelson L, Danila D, Pauler D, Miller C, Klibanski A. Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab 2000, 85: 3053-7.
27. Kayath M, Lengyel A, Vieira J. Prevalence and magnitude of osteopenia in patients with prolactinoma. Braz J Med Biol Res 1993, 26: 933-41.
28. Klibanski A, Neer R, Beitins I, Ridgway C, Zervas N, McArthur J. Decreased bone density in hyperprolactinemic women. N Engl J Med 1980, 303: 1511-4.
29. Braidman I, Baris C, Wood L, et al. Preliminary evidence for impaired estrogen receptor-alpha protein expression in osteoblasts and osteocytes from men with idiopathic osteoporosis. Bone 2000, 26: 423-7.
30. Morishima A, Grumbach M, Simpson E, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995, 80: 3689-98.
31. Ohgphipadhanakul B, Rajatanavin R, Chanprasertyothin S, Oiaseu N, Chailurkit L. Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 1998, 49: 803-9.
32. Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999, 84: 3626-35.
33. Carlsen CG, Soerensen TH, Eriksen EF. Prevalence of low serum estradiol levels in male osteoporosis. Osteoporos Int 2000, 11: 697-701.
34. Khosla S, Melton III L, Atkinson E, O'Fallon W. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001, 86: 3555-61.